1. Home
  2. COLL vs AHH Comparison

COLL vs AHH Comparison

Compare COLL & AHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLL
  • AHH
  • Stock Information
  • Founded
  • COLL 2002
  • AHH 1979
  • Country
  • COLL United States
  • AHH United States
  • Employees
  • COLL N/A
  • AHH N/A
  • Industry
  • COLL Biotechnology: Pharmaceutical Preparations
  • AHH Real Estate
  • Sector
  • COLL Health Care
  • AHH Finance
  • Exchange
  • COLL Nasdaq
  • AHH Nasdaq
  • Market Cap
  • COLL 1.1B
  • AHH 882.2M
  • IPO Year
  • COLL 2015
  • AHH 2013
  • Fundamental
  • Price
  • COLL $31.09
  • AHH $10.85
  • Analyst Decision
  • COLL Strong Buy
  • AHH Buy
  • Analyst Count
  • COLL 6
  • AHH 2
  • Target Price
  • COLL $42.00
  • AHH $11.88
  • AVG Volume (30 Days)
  • COLL 439.3K
  • AHH 583.5K
  • Earning Date
  • COLL 11-07-2024
  • AHH 11-04-2024
  • Dividend Yield
  • COLL N/A
  • AHH 7.50%
  • EPS Growth
  • COLL 757.11
  • AHH N/A
  • EPS
  • COLL 2.16
  • AHH N/A
  • Revenue
  • COLL $599,245,000.00
  • AHH $756,903,000.00
  • Revenue This Year
  • COLL $13.20
  • AHH N/A
  • Revenue Next Year
  • COLL $17.63
  • AHH $6.58
  • P/E Ratio
  • COLL $14.32
  • AHH N/A
  • Revenue Growth
  • COLL 9.62
  • AHH 19.33
  • 52 Week Low
  • COLL $28.97
  • AHH $10.02
  • 52 Week High
  • COLL $42.29
  • AHH $13.09
  • Technical
  • Relative Strength Index (RSI)
  • COLL 48.70
  • AHH 47.12
  • Support Level
  • COLL $29.67
  • AHH $10.82
  • Resistance Level
  • COLL $31.10
  • AHH $11.07
  • Average True Range (ATR)
  • COLL 0.98
  • AHH 0.18
  • MACD
  • COLL 0.26
  • AHH -0.00
  • Stochastic Oscillator
  • COLL 69.41
  • AHH 45.90

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About AHH Armada Hoffler Properties Inc.

Armada Hoffler Properties Inc is a real estate company. It engages in developing, building, owning and managing the high-quality, institutional-grade office, retail, and multifamily properties in various markets throughout the Mid-Atlantic and Southeastern United States. They lease our properties under operating leases and recognize base rents. It also recognize revenue from tenant recoveries, through which tenants reimburses the company for expenses paid by them such as utilities, janitorial, repairs and maintenance. The company's operating segment includes office real estate, retail real estate, multifamily residential real estate, and general contracting and real estate services. It generates maximum revenue from the general contracting and real estate services segment.

Share on Social Networks: